We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SCOTUS Snub of Momenta Maintains Expansive Safe Harbor Protections
SCOTUS Snub of Momenta Maintains Expansive Safe Harbor Protections
July 16, 2013
The Supreme Court’s decision June 24 not to review the Federal Circuit’s decision in Momenta v. Amphastar effectively maintains an expansive safe-harbor landscape for generic drugmakers that protects both pre- and post-approval activities that might otherwise infringe brand patents.